T72032 |
PI5P4Ks-IN-2
|
2766854-03-7
|
99.21%
|
|
PI5P4Ks-IN-2 is an inhibitor of the phosphatidylinositol 5-phosphate 4-kinase PI5P4Kγ. Targeting the PI5P4K isoforms, PI5P4Ks-IN-2 inhibited PI5P4Kα, PI5P4Kβ, PI...
|
T6850L |
GSK2292767 FA
|
T6850L
|
99.21%
|
|
GSK2292767 FA is a potent and selective inhibitor of PI3Kδ (pIC50 : 10.1).GSK2292767 FA is more than 500-fold more selective than other PI3K isoforms.GSK2292767 ...
|
T69742 |
SRX3177
|
2241237-51-2
|
99.16%
|
|
SRX3177 is a novel and potent inhibitor of BRD4, PI3K and CDK.SRX3177 has potential anticancer activity.
|
T1861 |
Omipalisib
|
1086062-66-9
|
99.16%
|
|
Omipalisib (GSK2126458) is a small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic activity.
|
T3826 |
Polygalasaponin F
|
882664-74-6
|
99.15%
|
|
Polygalasaponin F has anti-neuroinflammatory activity, can inhibit the release of inflammatory cytokines TNF-α and NO induced by lipopolysaccharides (LPS) and re...
|
T15420 |
GS-9901
|
1640247-87-5
|
99.14%
|
|
GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
|
T25399 |
ETP-45658
|
1198357-79-7
|
99.13%
|
|
ETP-45658 (ETP45658) is a PI 3-kinase inhibitor (IC50 values are 22, 30, 129 and 710 nM for PI 3-Kα, PI 3-Kδ, PI 3-Kβ and PI 3-Kγ respectively). Also inhibits DN...
|
T16355 |
NSC781406
|
1676893-24-5
|
99.08%
|
|
NSC781406 is a highly effective inhibitor of PI3K and mTOR (IC50: 2 nM for PI3Kα).
|
T5818 |
Rigosertib sodium
|
592542-60-4
|
99.07%
|
|
Rigosertib sodium (ON-01910), a non-ATP-competitive inhibitor of PLK1(IC50=9 nM), exhibits 30-fold higher specificity activity over Plk2 and no effect on Plk3.
|
T14998 |
Copanlisib dihydrochloride
|
1402152-13-9
|
99.05%
|
|
Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI...
|
T12367 |
Parsaclisib
|
1426698-88-5
|
99.02%
|
|
Parsaclisib (INCB050465) is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP)
|
T6799 |
IITZ-01
|
1807988-47-1
|
99%
|
|
IITZ-01 is potent autophagy inhibitor with single-agent anticancer activity ( IC50 of 2.62 μM for PI3Kγ.)
|
T2297 |
PIK-294
|
900185-02-6
|
99%
|
|
PIK-294 is a excellently specific p110δ inhibitor(IC50=10 nM).
|
T6510 |
GDC-0349
|
1207360-89-1
|
98.98%
|
|
GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases....
|
T2661 |
TGX-221
|
663619-89-4
|
98.98%
|
|
TGX-221, an effective, specific, and cell membrane permeable inhibitor of the PI3K p110β catalytic subunit, is utilized for cancer treatment.
|
T6732 |
WYE-687
|
1062161-90-3
|
98.98%
|
|
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(...
|
T16529 |
BEBT-908
|
1235449-52-1
|
98.96%
|
|
BEBT-908 (PI3Kα inhibitor 1) is a selective PI3Kα inhibitor (IC50 <0.1 μM). BEBT-908 also inhibits HDAC (0.1 μM≤IC50≤1 μM).
|
T2672 |
TG100-115
|
677297-51-7
|
98.95%
|
|
TG100-115 is a PI3Kγ/δ inhibitor (IC50: 83/235 nM), with fewer effects on PI3Kα/β.
|
TN1134 |
Euscaphic acid
|
53155-25-2
|
98.93%
|
|
Euscaphic acid has anti-diabetic, and anti-inflammatory activities, it inhibits LPS-induced inflammatory responses by interference with the clustering of TRAF6 w...
|
TN1299 |
Desmethylglycitein
|
17817-31-1
|
98.93%
|
|
Desmethylglycitein (6,7,4'-Trihydroxyisoflavone) , is a novel inhibitor of PKCα in suppressing solar UV-induced matrix metalloproteinase 1, which has antioxidant...
|